|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Top Lists |
Insider Trading Graph View |
Insider Watch |
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise" - Peter Lynch ==>> What is insider trading>> |

| Transaction & Date | Reported Date |
Company | Symbol | Insider Relationship |
Shares Traded | Average Price | Total Amount |
Shares Ownership |
Filing |
| 2009-05-26- -2009-05-27 Sale |
2009-05-28 4:21 pm | MAP Pharmaceuticals, Inc. | MAPP | ARMER THOMAS A (Chief Scientific Officer Director) | 100,000 | $9.606 | $960,600 | 332,403 (Indirect) | View |
| Transaction & Date |
Reported Date |
Company | Symbol | Insider Relationship | Shares Traded | Average Price |
Total Amount |
Shares Ownership |
Filing |
| 2009-05-27 Exercise |
2009-05-28 4:21 pm | MAP Pharmaceuticals, Inc. | MAPP | ARMER THOMAS A (Chief Scientific Officer Director) | 60,000 | $0.7434 | $44,604 | 392,403 (Indirect) |
View |
| Transaction & Date |
Reported Date | Exercisable Expiration | Company | Symbol | Insider Relationship |
Shares Traded |
Conversion Price | Shares Ownership |
Filing |
| 2009-05-27 Exercise |
2009-05-28 4:21 pm | N/A 2016-01-23 |
MAP Pharmaceuticals, Inc. | MAPP | ARMER THOMAS A (Chief Scientific Officer Director) | 60,000 | $0.7434 | 35,846 (Direct) | View |
| 2009-02-11 Option Award | 2009-02-13 5:10 pm |
N/A 2019-02-10 | MAP Pharmaceuticals, Inc. | MAPP | ARMER THOMAS A (CSO, Director Director) | 75,000 | $10.37 | 75,000 (Direct) | View |
| 2008-01-22 Option Award | 2008-01-24 6:52 pm | N/A 2018-01-21 | MAP Pharmaceuticals, Inc. | MAPP | ARMER THOMAS A (CSO, Director Director) | 50,000 | $13.12 | 50,000 (Direct) | View |
|
© 2005-2009 SecForm4.Com All rights reserved. Archives: 2009 2008 2007 2006 2005 2004 ... Sun, 22 Nov 2009 04:51:58 -0600 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC. SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |